Evidence map›Paper›PMID 36861993›Full record

ArticleMicrobiology resource announcements2023

Draft Genome Sequence of the Fluconazole-Resistant Yarrowia lipolytica Clinical Isolate CBS 18115.

Rose-Anne Lavergne, Paul Barbier, Lenha Mobuchon, Atanu Banerjee, Rajendra Prasad, Florent Morio

Abstract read
In one paragraph

Article in Microbiology resource announcements, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. An update on clinically relevant, rare, and emergingClinical microbiology reviews · 2025
    Review
  2. The association ofMedical mycology case reports · 2025
    Article
  3. Article
  4. Journal of fungi (Basel, Switzerland) · 2024
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rose-Anne LavergneNantes Université, CHU Nantes, Cibles et Médicaments des Infections et de l'Immunité, UR1155, Nantes, France.
Paul BarbierService de Virologie, CHU Nantes, Nantes, France.
Lenha MobuchonNantes Université, CHU Nantes, Biology Department, Nantes, France.
Atanu BanerjeeAmity Institute of Biotechnology, Amity University Haryana, Gurugram, India.
Rajendra PrasadAmity Institute of Biotechnology, Amity University Haryana, Gurugram, India.
Florent MorioNantes Université, CHU Nantes, Cibles et Médicaments des Infections et de l'Immunité, UR1155, Nantes, France.ORCID 0000-0002-5859-6105

Funding

Department of Biotechnology, Ministry of Science and Technology, India (DST) BT/PR32349/MED/29/1456/2019
6 · The paper itself

Abstract

Yarrowia lipolytica is a nonconventional yeast of industrial interest that can sometimes act as an opportunistic pathogen and is responsible for invasive fungal infections. We report the draft genome sequence of the fluconazole-resistant strain CBS 18115, which was isolated from a blood culture. The Y132F substitution in

Identifiers

PMID36861993
PMCPMC10112134

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.